David W. Andrews
Professor
Department of Biochemistry
University of Toronto
Canada
Biography
Dr. Andrews has served as President of the Canadian Federation of Biological Societies and of the Canadian Society of Biochemistry, Molecular and Cellular Biology and contributed to their advocacy activities for 11 years. As part of the Partnership Group for Science and Engineering he was an invited speaker at the Canadian Parliament and has been a speaker in many public forums including Science in the City and the Canadian Cancer Society. He is a contributing member of the Faculty of 1000 (www.facultyof1000.com) and is on the editorial board of BMC Cell Biology. Dr. Andrews is active in the private sector where he was a founding partner in MBI Fermentas and a member of the Scientific Advisory Board of Isogenica Ltd., Cambridge, England. He holds two patents licensed to industry and has two additional patents submitted. Recent private sector research projects include research for PerkinElmer, Spectral Applied Research, Abbott and Genentech.
Research Interest
Manipulating Programmed Cell Death to Kill Cancer
